Breakthrough in Vision Restoration for AMD Patients
A recent study has demonstrated that several dozen patients suffering from age-related macular degeneration (AMD), a progressive form of blindness, have regained some central vision through an innovative eye implant paired with smart glasses. The findings were published in The New England Journal of Medicine. Researchers noted that patients could utilize the technology to engage in activities like solving crossword puzzles and reading standard books once more. The study involved individuals aged 60 and older who had been diagnosed with AMD in both eyes, displaying a significant visual impairment.
AMD leads to irreversible vision loss as cells in the central retina deteriorate over time. This study aimed to restore some of that lost vision using a small device—2 by 2 millimeters—comprised of tiny photovoltaic solar panels. This device was surgically implanted beneath the retina of participants’ eyes. Equipped with camera-enabled smart glasses, patients transmitted zoomed images of their surroundings to the retinal implant via near-infrared light. The implant, in turn, emitted small electrical pulses to the optic nerve, simulating the function of healthy retinal cells.
Initially, 38 patients received the retinal implant, with 32 remaining for the full year of the clinical trial. By the end of the year, 26 of these participants demonstrated improved vision—a success rate of 80 percent. The enhancement, while notable, still resulted in only blurry black-and-white vision for the patients. Nonetheless, experts outside the study have referred to the results as “amazing,” with some media outlets highlighting its significance.
This technology was developed by Science Corporation, a brain-computer interface firm founded by Max Hodak, who also co-founded Neuralink. Science Corporation acquired the retinal implant technology from the French medical device company Pixium Vision in 2024, following Pixium’s financial struggles after working for a decade to advance the vision technology. A similar scenario unfolded for Second Sight Medical, another firm in the vision prosthesis space, which faced setbacks but later saw its technology revived by a new startup, allowing clinical trials to progress.
